Has_circ_0055625 from circRNA profile increases colon cancer cell growth by sponging miR-106b-5p

被引:49
|
作者
Zhang, Jian [1 ]
Liu, Hua [1 ]
Zhao, Ping [1 ]
Zhou, Hao [1 ]
Mao, Tao [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Dept Gen Surg, 16 Jiangsu Rd, Qingdao 266003, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
circRNA; colon cancer; hsa_circ_0055625; ITGB8; miR-106b; COLORECTAL-CANCER; EXPRESSION; PROMOTES;
D O I
10.1002/jcb.27355
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Circular RNAs (circRNA) are endogenous noncoding RNAs and play important roles in cancer; however, the roles of circRNAs in colon cancer are far from clear. The circRNA expression profile in colon cancer tissues was analyzed by microarray. The data from microarray showed that there were 198 upregulated and 136 downregulated circRNAs in colon cancer tissues. Among the top 10 upregulated circRNAs, hsa_circ_0055625 (circ_0055625) was confirmed to be significantly upregulated in colon cancer tissues. Further analysis demonstrated that circ_0055625 might get involved in the pathogenesis of colon cancer by functioning as miRNA sponges and performed bioinformatics analysis of the predicted circ_0055625/miR-106b-5p (miR-106b)/ITGB8 network. Moreover, we found that circ_0055625 expression was associated with pathological TNM stage and metastasis. These data indicated that circ_0055625/miR-106b/ITGB8 played a role in promoting tumor growth and metastasis, which suggested that circ_0055625 was a potential biomarker of colon cancer.
引用
收藏
页码:3027 / 3037
页数:11
相关论文
共 50 条
  • [11] miR-106b-5p in stage II left-sided and right-sided colon cancer and its association with the prognostic characteristics of patients
    Zhou, Siwei
    Sui, Wenyan
    Wang, Yiming
    Zhong, Guofang
    Yuan, Xia
    ONCOLOGY LETTERS, 2025, 29 (01)
  • [12] CircRNA CBL.11 suppresses cell proliferation by sponging miR-6778-5p in colorectal cancer
    Hongbin Li
    Xiaodong Jin
    Bingtao Liu
    Pengcheng Zhang
    Weiqiang Chen
    Qiang Li
    BMC Cancer, 19
  • [13] Circ-PRKCI Alleviates Lipopolysaccharide-induced Human Kidney 2 Cell Injury by Regulating miR-106b-5p/GAB1 Axis
    Xiong, Yueli
    Wang, Yang
    Tian, Hui
    Li, Yuanyuan
    Xu, Qingjie
    He, Zhenkun
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (04) : 523 - 533
  • [14] E2F7, EREG, miR-451a and miR-106b-5p are associated with the cervical cancer development
    Zong, Shan
    Liu, Xiaoxia
    Zhou, Na
    Yue, Ying
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 299 (04) : 1089 - 1098
  • [15] Deregulation of circRNA hsa_circ_0009109 promotes tumor growth and initiates autophagy by sponging miR-544a-3p in gastric cancer
    Zhang, Weiwei
    Yang, Qian
    Qian, Dongchen
    Zhao, Keli
    Tang, Chenxue
    Ju, Shaoqing
    GASTROENTEROLOGY REPORT, 2023, 12
  • [16] miR-106b-5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma
    He, Chuan
    Chen, Hongwei
    Liu, Yan
    Li, Xiaolin
    Zhang, Chaoju
    Qin, Qunyan
    Pang, Qixiong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (05) : 3203 - 3210
  • [17] E2F7, EREG, miR-451a and miR-106b-5p are associated with the cervical cancer development
    Shan Zong
    Xiaoxia Liu
    Na Zhou
    Ying Yue
    Archives of Gynecology and Obstetrics, 2019, 299 : 1089 - 1098
  • [18] MiR-106b-5p Protects against Islet β-Cell Dysfunction and Apoptosis by Modulating the Endoplasmic Reticulum Homeostasis Pathway
    Xu, Weilong
    Yu, Jiangyi
    Zhou, Xiqiao
    DIABETES, 2024, 73
  • [19] MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer
    Wei, Ke
    Pan, Chunfeng
    Yao, Guoliang
    Liu, Bin
    Ma, Teng
    Xia, Yang
    Jiang, Wei
    Chen, Liang
    Chen, Yijiang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 44 (04) : 1545 - 1558
  • [20] CircRNA circ_SEC24A upregulates DNMT3A expression by sponging miR-26b-5p to aggravate osteoarthritis progression
    Zhang, Zhongqiang
    Yang, Bo
    Zhou, Shuping
    Wu, Junxing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 99